GENBGenerate Biomedicines Inc. Common Stock
16.12USD-5.01%Mkt Cap: 2.07B $P/E: —3d ago
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses pro…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.07B $
Enterprise Value1.66B $
Revenue (TTM)26.48M $
Gross Profit-213.80M $
Net Income (TTM)-203.15M $
Revenue/Share0.3230 USD
Last Price16.12 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees312
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.01
PEG—
EV/EBITDA-6.64
EV/Revenue62.59
P/S77.50
P/B4.50
EPS (TTM)-1.97
EPS (Forward)-2.28
52W Range
11.0072% of range18.16
52W High18.16 USD
52W Low11.00 USD
Profitability
Gross Margin0.00%
Oper. Margin-1134.21%
EBITDA Margin0.00%
Profit Margin-636.99%
ROE32.98%
ROA-61.53%
Growth
Revenue Growth-37.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-200.62M $
CapEx (TTM)3.51M $
FCF Margin—
FCF Yield—
Net Debt-394.79M $
Net Debt/EBITDA1.58
Balance Sheet
Debt/Equity-0.11
Current Ratio8.30
Quick Ratio8.08
Book Value/Sh3.555 USD
Cash/Share3.564 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)25.60 USD
Upside (mean)+58.8%
Target Range22.00 USD – 30.00 USD
$22.00+58.8% to mean$30.00
# Analysts5
Ownership
Shares Out.128.35M
Float60.45M
Insiders14.05%
Institutions77.59%
Short Interest
Short Ratio11.4d
Short % Float9.73%
Short % Out.5.67%
Shares Short7.28M
Short (prev mo.)5.92M
Technical
SMA 5014.77 (+9.1%)
SMA 20013.69 (+17.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)551.18K
Avg Vol (10d)670.49K
Technical Indicators
RSI (14)59.8
MACD0.4955
MACD Signal0.2720
MACD Hist.+0.2235
BB Upper16.86 USD
BB Middle14.74 USD
BB Lower12.63 USD
BB Width28.64%
ATR (14)0.9576 USD
Vol Ratio (20d)1.38x